Specific Anti-Leukemic Activity of the Peptide Warnericin RK and Analogues and Visualization of Their Effect on Cancer Cells by Chemical Raman Imaging

PLoS One. 2016 Sep 6;11(9):e0162007. doi: 10.1371/journal.pone.0162007. eCollection 2016.

Abstract

Antimicrobial peptides can be used as therapeutic agents against cancer cells. Warnericin RK and derivatives (WarnG20D and WarnF14V) were tested on various, solid tumor or leukemia, cancer cells. These peptides appeared to be cytotoxic on all the cell types tested, cancerous as well healthy, but very interestingly displayed no deleterious effect on healthy mononuclear cells. The mode of action of the peptide was proposed to be membranolytic, using chemical Raman imaging. Addition of peptide induced a large disorganization of the membrane leading to the loss of the content of inner compartments of Jurkat cell, whereas no effect was observed on the healthy mononuclear cells. The less hemolytic peptides WarnG20D and WarnF14V could be good candidates for the leukemia treatment.

MeSH terms

  • Animals
  • Antimicrobial Cationic Peptides / pharmacology*
  • Antineoplastic Agents / pharmacology*
  • Astrocytes / cytology
  • Astrocytes / drug effects
  • Bacteriocins / pharmacology*
  • Cell Line, Tumor
  • Cell Membrane Permeability / drug effects
  • Cell Survival / drug effects
  • Cerebral Cortex / cytology
  • Cerebral Cortex / drug effects
  • Erythrocytes / drug effects
  • Hemolysis / drug effects
  • Humans
  • Jurkat Cells
  • K562 Cells
  • Leukocytes, Mononuclear / cytology
  • Leukocytes, Mononuclear / drug effects
  • Mice
  • Microscopy, Confocal
  • Neuroglia / drug effects*
  • Neuroglia / pathology
  • Organ Specificity
  • Primary Cell Culture
  • Rats
  • Spectrum Analysis, Raman

Substances

  • Antimicrobial Cationic Peptides
  • Antineoplastic Agents
  • Bacteriocins
  • warnericin RK, Staphylococcus warneri

Grants and funding

The authors received no specific funding for this work.